loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 212121 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    CMP Pharma, Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CMP DEV LLC (1)

    filter

    01 SOLUTION;INTRAVENOUS (1)

    filter

    01 RX (1)

    filter

    01 POTASSIUM PHOSPHATES (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

      PDF Supplier PDF
      URL Supplier Web Content
      SOLUTION; INTRAVEN...
      4.5GM/15ML (300MG/...
      2019-09-19
      212121
      POTASSIUM PHOSPHAT...
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for FDA Orange Book APPLICATION 212121

      Looking for FDA Orange Book APPLICATION 212121 1

      19

      CMP Pharma, Inc., based in U.S.A, is a pharmaceutical company.

      One of their notable products is POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC, with a corresponding application number 212121.

      Regulatory Information RX

      With a dosage strength 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML)

      Dosage Form Route SOLUTION; INTRAVENOUS

      Reference Listed Drug Yes

      Approved since 2019-09-19

      Post Enquiry
      POST ENQUIRY